Skip to main content
Equibles

Amundi

Position in RDY — Dr Reddys Laboratories Ltd

CIK 1330387 Paris, I0
Back to RDY Full portfolio

Position in RDY

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$652,050
+$28,800 QoQ
Shares Held
45,000
0.0% QoQ
Ownership
0.005%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#96
of 238 holders
Holding Since
Jun 2021
21 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in RDY Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Amundi holds $594,123,116 across 28 Drug Manufacturers - Specialty & Generic names. RDY ranks #14 (0.1% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 3,988,618 $286,622,087
2 UTHR
UNITED THERAPEUTICS Corp
 219,094 $118,711,701
3 TEVA
Teva Pharmaceutical Industries Ltd
 1,929,853 $65,383,418
4 VTRS
Viatris Inc
 3,269,550 $51,920,453
5 NBIX
Neurocrine Biosciences Inc
 220,463 $37,156,833
6 ALKS
Alkermes plc.
 217,739 $11,409,523
7 LNTH
Lantheus Holdings, Inc.
 82,089 $9,106,952
8 ANIP
Ani Pharmaceuticals Inc
 31,793 $2,631,824

All Filings in RDY

Export CSV
21 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $652,050 45,000
2026-03-31 $623,250 45,000
2025-12-31 $631,800 45,000
2025-09-30 $1,376,331 98,450
2025-06-30 $1,479,703 98,450
2025-03-31 $1,298,555 98,450
2024-12-31 $1,554,525 98,450
2024-09-30 $1,190,955 14,990
2024-06-30 $1,148,411 15,073
2024-03-31 $1,168,831 15,935
2023-12-31 $6,759,140 97,142
2023-09-30 $2,572,087 38,464
2023-06-30 $1,827,918 28,964
2023-03-31 $1,529,367 26,864
2022-12-31 $1,866,312 36,064
2022-09-30 $1,243,807 23,764
2022-06-30 $3,404,490 61,464
2022-03-31 $2,712,044 48,664
2021-12-31 $4,340,280 66,355
2021-09-30 $5,514,426 84,655
2021-06-30 $4,870,404 66,255